Literature DB >> 10501537

Brain hemorrhages after rt-PA treatment of embolic stroke in spontaneously hypertensive rats.

G Brinker1, F Pillekamp, K A Hossmann.   

Abstract

Intracerebral hemorrhage is a major complicating factor of thrombolytic therapy of stroke. To investigate the incidence of bleeding in animals with a diseased vascular system, thrombolysis was carried out in spontaneously hypertensive rats (SHR) after clot embolism of the right middle cerebral artery (MCA). Three hours after embolism SHR were treated with either recombinant tissue-plasminogen activator (rt-PA) or saline, and neurological deficits and intracerebral hemorrhages were evaluated after 3 days survival. Rt-PA-treated SHR exhibited a significantly higher incidence of hemorrhages than untreated rats but neurological deficits and survival rates showed a non-significant trend for improvement. This model offers the possibility of investigating the pathophysiology of post-thrombolytic complications in a clinically relevant small animal model.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10501537     DOI: 10.1097/00001756-199906230-00027

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  8 in total

1.  Two-kidney one-clip is a pertinent approach to integrate arterial hypertension in animal models of stroke: Serial magnetic resonance imaging studies of brain lesions before and during cerebral ischemia.

Authors:  Benjamin Ménard; Laurent Chazalviel; Simon Roussel; Myriam Bernaudin; Omar Touzani
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-15       Impact factor: 6.200

2.  Protective Effects of Autologous Bone Marrow Mononuclear Cells After Administering t-PA in an Embolic Stroke Model.

Authors:  Bing Yang; Weilang Li; Nikunj Satani; Duyen M Nghiem; XiaoPei Xi; Jaroslaw Aronowski; Sean I Savitz
Journal:  Transl Stroke Res       Date:  2017-08-23       Impact factor: 6.829

3.  Reperfusion-associated hemorrhagic transformation in SHR rats: evidence of symptomatic parenchymal hematoma.

Authors:  Erica C Henning; Lawrence L Latour; John M Hallenbeck; Steven Warach
Journal:  Stroke       Date:  2008-08-28       Impact factor: 7.914

Review 4.  Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly.

Authors:  A R Green
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

5.  Mild hypothermia reduces tissue plasminogen activator-related hemorrhage and blood brain barrier disruption after experimental stroke.

Authors:  Xian Nan Tang; Liping Liu; Maya A Koike; Midori A Yenari
Journal:  Ther Hypothermia Temp Manag       Date:  2013-06       Impact factor: 1.286

6.  Animal models of ischemic stroke. Part two: modeling cerebral ischemia.

Authors:  Marco Bacigaluppi; Giancarlo Comi; Dirk M Hermann
Journal:  Open Neurol J       Date:  2010-06-15

7.  Symptomatic hemorrhage after alteplase therapy not due to silent ischemia.

Authors:  M D Hill; P A Barber; A M Demchuk; R J Sevick; R Frayne; A M Buchan
Journal:  BMC Neurol       Date:  2001-12-18       Impact factor: 2.474

8.  Extract of Antrodia camphorata exerts neuroprotection against embolic stroke in rats without causing the risk of hemorrhagic incidence.

Authors:  Ye-Ming Lee; Chiu-Yun Chang; Ting-Lin Yen; Pitchairaj Geraldine; Chang-Chou Lan; Joen-Rong Sheu; Jie-Jen Lee
Journal:  ScientificWorldJournal       Date:  2014-07-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.